The effect of TILs in NSCLC is best documented in the SCC subgroup, while the data presented herein indicate that CD66b+ TANs to be a candidate in TNM-I for the ADC subgroup. This evidence concerns the gene CEACAM8 and non-small cell lung carcinoma.